SVFX

SVFX assigns pathogenicity scores to structural variants (SVs), including large deletions and duplications, using a mechanism-agnostic machine-learning approach to prioritize SVs by predicted pathogenic impact.


Key Features:

  • Machine learning framework: Uses Random Forest algorithms to assign pathogenicity scores and prioritize SVs.
  • Mechanism-agnostic workflow: Applies a mechanism-agnostic workflow to score SVs independent of assumed molecular mechanisms.
  • SV types: Targets structural variants including large deletions and duplications.
  • Somatic and germline models: Generates predictive models for both somatic and germline structural variants.
  • Feature integration: Incorporates genomic, epigenomic, and conservation-based attributes derived from SV call sets in diseased and healthy individuals.
  • Pathogenic vs benign discrimination: Trains on comprehensive datasets to distinguish pathogenic SVs from benign variants.
  • Cancer enrichment: When applied to cancer cohorts, enriches for known cancer genes and pathways associated with cancer-related SVs.

Scientific Applications:

  • SV prioritization in disease studies: Prioritizes structural variants by predicted pathogenic impact for disease-relevant analyses.
  • Somatic and germline SV analysis: Enables separate analysis and modeling of somatic and germline SVs in cohort studies of diseased and healthy individuals.
  • Cancer genomics: Identifies and enriches for cancer genes and pathways associated with structural variants in cancer cohorts.

Methodology:

Employs a mechanism-agnostic workflow using Random Forest algorithms trained on genomic, epigenomic, and conservation-based features derived from SV call sets in diseased and healthy individuals.

Topics

Details

License:
MIT
Programming Languages:
Python
Added:
1/18/2021
Last Updated:
2/24/2021

Operations

Publications

Kumar S, Harmanci A, Vytheeswaran J, Gerstein MB. SVFX: a machine learning framework to quantify the pathogenicity of structural variants. Genome Biology. 2020;21(1). doi:10.1186/s13059-020-02178-x. PMID:33168059. PMCID:PMC7650198.

PMID: 33168059
PMCID: PMC7650198
Funding: - National Institutes of Health: U24HG007497